Emma Duncan
Queensland University of Technology, QLD, Australia
- This delegate is presenting an abstract at this event.

Prof Emma Duncan has been fascinated by endocrinology in general and the skeleton specifically since her undergraduate days, leading to adventures around the globe. A long stint in the UK encompassed a PhD in osteoporosis genetics and consultant training; and she returned to Australia in 2005. Since then, Emma has published multiple high-impact publications investigating osteoporosis, skeletal dysplasias, MODY [maturity-onset diabetes of the young], phaeochromocytomas and paragangliomas, thyroid cancer, obstetric medicine….and she played a pioneering role in the translation of massively parallel sequencing technologies into clinical practice. In her spare time she serves as the immediate past president of ANZBMS and contributes to leadership and governance nationally and internationally.
Presentations this author is a contributor to:
Mutations in MAP3K7 and TAB2 cause a distinct autosomal dominant form of frontometaphyseal dysplasia through a gain-of-function mechanism (#29)
4:20 PM
Emma M Wade
Outstanding abstracts
Idiopathic osteoporosis may be due to variants in osteogenesis imperfecta genes (#88)
4:54 PM
Aideen M McInerney-Leo
Advances in bone biology (II) and Late-breaking abstracts
Homozygous variant in Cathepsin K in a family with multiple cases of bilateral atypical femoral fracture but without clinical features of pyknodysostosis (#87)
4:42 PM
Sue Lynn Lau
Advances in bone biology (II) and Late-breaking abstracts